R01 CA125063-01/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2009	3
2010	5
2011	2
2013	1
2014	2
2024	0

1

Diversity and censoring of landscape phage libraries.

Kuzmicheva GA, Jayanna PK, Sorokulova IB, Petrenko VA. Kuzmicheva GA, et al. Protein Eng Des Sel. 2009 Jan;22(1):9-18. doi: 10.1093/protein/gzn060. Epub 2008 Nov 6. Protein Eng Des Sel. 2009. PMID: 18988692 Free PMC article.

2

Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.

Wang T, Hartner WC, Gillespie JW, Praveen KP, Yang S, Mei LA, Petrenko VA, Torchilin VP. Wang T, et al. Nanomedicine. 2014 Feb;10(2):421-30. doi: 10.1016/j.nano.2013.08.009. Epub 2013 Sep 9. Nanomedicine. 2014. PMID: 24028893 Free PMC article.

3

Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.

Wang T, Yang S, Mei LA, Parmar CK, Gillespie JW, Praveen KP, Petrenko VA, Torchilin VP. Wang T, et al. Mol Cancer Ther. 2014 Dec;13(12):2864-75. doi: 10.1158/1535-7163.MCT-14-0052. Epub 2014 Sep 19. Mol Cancer Ther. 2014. PMID: 25239936 Free PMC article.

4

Landscape phage ligands for PC3 prostate carcinoma cells.

Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. Jayanna PK, et al. Protein Eng Des Sel. 2010 Jun;23(6):423-30. doi: 10.1093/protein/gzq011. Epub 2010 Feb 25. Protein Eng Des Sel. 2010. PMID: 20185523 Free PMC article.

5

Mutations in fd phage major coat protein modulate affinity of the displayed peptide.

Kuzmicheva GA, Jayanna PK, Eroshkin AM, Grishina MA, Pereyaslavskaya ES, Potemkin VA, Petrenko VA. Kuzmicheva GA, et al. Protein Eng Des Sel. 2009 Oct;22(10):631-9. doi: 10.1093/protein/gzp043. Epub 2009 Jul 25. Protein Eng Des Sel. 2009. PMID: 19633313 Free PMC article.

6

On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters.

Wang T, Kulkarni N, D'Souza GG, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2011 Oct 3;8(5):1720-8. doi: 10.1021/mp200080h. Epub 2011 Jul 29. Mol Pharm. 2011. PMID: 21675738 Free PMC article.

7

Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes.

Bedi D, Musacchio T, Fagbohun OA, Gillespie JW, Deinnocentes P, Bird RC, Bookbinder L, Torchilin VP, Petrenko VA. Bedi D, et al. Nanomedicine. 2011 Jun;7(3):315-23. doi: 10.1016/j.nano.2010.10.004. Epub 2010 Nov 2. Nanomedicine. 2011. PMID: 21050894 Free PMC article.

8

Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.

Wang T, Yang S, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2010 Aug 2;7(4):1149-58. doi: 10.1021/mp1000229. Mol Pharm. 2010. PMID: 20438086 Free PMC article.

9

Liposomes targeted by fusion phage proteins.

Jayanna PK, Torchilin VP, Petrenko VA. Jayanna PK, et al. Nanomedicine. 2009 Mar;5(1):83-9. doi: 10.1016/j.nano.2008.07.006. Epub 2008 Oct 1. Nanomedicine. 2009. PMID: 18838343 Free PMC article.

10

Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.

Wang T, Petrenko VA, Torchilin VP. Wang T, et al. Mol Pharm. 2010 Aug 2;7(4):1007-14. doi: 10.1021/mp1001125. Mol Pharm. 2010. PMID: 20518562 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year